Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adeghate, E., Ember, Z., Donath, T., Pallot, D.J., and Singh, J., 1996, Immunohistochemical identification and effects of atrial natriuretic peptide, pancreastatin, leucine-enkephalin, and galanin in the porcine pancreas. Pancreas 17:503–509.
Ahren, B., Lindskog, S., Tatemoto, K., and Efendic, S., 1988, Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Diabetes 37:281–285.
Ahren, B., Bertrand, G., Roye, M., and Ribes, G., 1996, Pancreastatin modulates glucosestimulated insulin secretion from the perfused rat pancreas. Acta Physiol. Scand. 158:63–70.
Arden, S.D., Rutherford, N.G., Guest, P.C., Curry, W.J., Bailyes, Johnston, C.F., and Hutton, J.C., 1994, The post-translational processing of chromogranin A in the pancreatic islet: involvement ofthe eukaryote subtilisin PC2. Biochem. J. 298:521–528.
Bretherton-Watt, D., Valentino, K.L., Tatemoto, K., Roth, K., Polak, J.M., and Bloom, S.R., 1988, Pancreastatin distribution ans plasma levels in the pig. Peptides 9:1005–1014.
Cohn, D.V., Zangerle, R., Fischer-Colbrie, R., Chu, L.L.H., Elting, J.J., Hamilton, J.W., and Winkler, H., 1982, Similarity of secretory protein I from parathyroid gland to chromogranin A from adrenal medulla. Proc. Natl. Acad. Sci. USA 79:387–390.
Coimbra, C.C., and Migliorini, R.H., 1986, Insulin-sensitive glucoreceptors in rat preoptic area that regulate FFA mobilization. Am. J. Physiol. 251:E703–706.
Cryer, P.E., Wortsman, J., Shah, S.D., Nowak, A.M., and Deftos, L.J., 1991, Plasma chromogranin-A as a marker of sympathochromaffin activity in humans. Am. J. Physiol. 260:E243–E246.
Curry, W.J., Johnston, C.F., Shaw, C., and Buchanan, K.D., 1990, Distribution and partial characterization of immunoreactivity to the putative C-terminus of rat pancreastatin. Regul. Pept. 30:207–219.
Curry, W.J., Johnston, C.F., Hutton, J.C., Arden, S.N., Rutherford, N.G., Shaw, C., and Buchanan, K.D., 1991, The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera. Histochemistry 96:531–538.
Drees, B.M., and Hamilton, J.W., 1992, Pancreastatin and bovine parathyroid cell secretion. Bone and Mineral 17:335–346.
Efendic, S., Tatemoto, K., Mutt, V., Quan, C., Chang, D., Ostenson, C.G., 1987, Pancreastatin and islet hormone release. Proc.Natl. Acad. Sci. USA 84:7257–7260.
Fasciotto, B.H., Gorr, S.U., DeFranco, D.J., Levine, M.A., and Cohn, D.V., 1989, Pancreastatin, a presumed product of chromogranin A (secretory protein I) processing, inhibits secretion from porcine parathyroid cells in culture. Endocrinology 125:1617–1622.
Fasciotto, B.H., Gorr, S.U., Bourdeau, A.M., and Cohn, D.V., 1990, Autocrine regulation of parathyroid secretion inhibition of secretion by chromogranin-A (secretory protein-I) and potentiation of secretion by chromogranin-A and pancreastatin antibodies. Endocrinology 127:1329–1335.
Flood, J.F., Morley, J.E., and Tatemoto, K.. 1988, Effects of systemic pancreastatin on memory retention. Peptides 9:1077–1080.
Funakoshi, A., Miyasaka, Kitani, K., and Tatemoto, K., 1989b, Effect of pancreastatin on pancreatic endocrine function in the conscious rat. Regul. Pept. 24:225–231.
Funakoshi, A., Miyasaka, K., Kitani, K., Tamamura, H., Funakoshi, S., and Yajima, H., 1989c, Bioactivity of synthesis C-terminal fragment of rat pancreastatin on endocrine pancreas. Biochem. Biophys. Res. Commun. 158:844–849.
Funakoshi, A., Miyasaka, K., Nakamura, R., Kitani, K., and Tatemoto, K., 1989d, Inhibitory effect of pancreastatin on pancreatic exocrine secretion in the conscious rat. Regul. Pept. 25:157–166.
Funakoshi, A., Tateishi, K., Shinozaki, H., Matsumoto, M., and Wakasugi, H., 1990b, Elevated plasma levels of pancreastatin (PST) in patients with non-insulindependent diabetes mellitus (NIDDM). Regul. Pept. 30:159–164.
Gomez, G., Udupi, V., and Greeley, G.H., 1997, Comparison of somatostatin and pancreastatin on secretion of gastrin, pancreatic polypeptide, and peptide YY. Proc. Soc. Exp. Biol. Med. 215:165–167.
González-Yanes, C., and Sánchez-Margalet, V., 2000, Pancreastatin modulates insulin signaling in rat adipocytes. Mechanisms of cross-talk. Diabetes (in press).
González-Yanes, C., Santos-Alvarez, J., and Sánchez-Margalet, V., 1999, Characterization of pancreastatin receptors and signaling in adipocyte membranes. Biochim. Biophys. Acta 1451:153–162.
Gorr, S.U., and Pence, S.S., 1995, Pancreastatin stimulates secretion from neonatal rat atrial cells. J. Mol. Cell. Cardiol. 27:767–771.
Haberstock-Debic, H., Banfic, H., Stevens, W.J., De Clerck, L.S., Wechsung, E., and De Potter, W., 1997, Stimultion of T-cell proliferaton by pancreastatin and its C-terminal fragment (33–49). Neuroimmunomodulation 4:244–249.
Hakanson, R., Chen, D., Andersson, K., Mattson, H., and Sundler, F., 1993, The biology and physiology ofthe ECL cell. Yule J. Biol. Med. 67:123–128.
Hakanson, R., Ding, X.Q., Norlen, P., and Chen, D., 1995, Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rats tomach. Gastroenterology 108: 1445–1452.
Hashimoto, T., Kogire, M., Lluis, F., Gomez, G., Tatemoto, K., Greeley, G.H., and Thompson, J.C., 1990, Stimulatory effect of pancreastatin on gastric acid secretion in conscious dogs. Gastroenterology 99:61–65.
Herzig, K.H., Louie, D.S., Tatemoto, K., and Chung, O.Y., 1992, Pancreastatin inhibits pancreatic enzyme secretion by presynaptic modulation of acetylcholine release. Am. J. Physiol. 262:G113–Gl17.
Hertelendy, Z.I., Patel, D.G., and Knittel, J.J., 1996, Pancreastatin inhibits insulin secretion in RIN m5F cells through the obstruction of G-protein mediated calciumdirected exocytosis. Cell Calcium 19:125–132.
Holst, J.J., Östenson, C.G., Harling, H., and Messell, T., 1990, Porcine pancreastatin has no effect on endocrine secretion from the pig pancreas. Diabetologia 33:403–406.
Hutton, J.C., Nielsen, E, and Kastern, W., 1988, The molecular cloning of chromogranin A-like precursor of betagranin and pancreastatin fiom the endocrine pancreas. FEBS Lett. 236:269–274.
Inui, A., Okita, M., Inoue, T., Sakatani, N., Oya, M., Morioka, H., Oimomi, M., Tatemoto, K., and Baba, S., 1989, Effects of pancreastatin on insulin and pancreatic polypeptide secretion in the dog. Endocrinologia Japonica 36:733–738.
Ishizuka, J., Singh, P., Greeley, G.H., Towsend, CM., Cooper, C.W., Tatemoto, K., and Thompson, J.C., 1988, A comparison of the insulinotropic and the insulin-inhibitory actions of gut peptides on new born and adult rat islet cells. Pancreas 3:77–82.
Ishizuka, J., Asadan, I., Poston, G.-J., Lluis, F., Tatemoto, K., Greeley, G.H., and Thompson, J.C., 1989, Effect of pancreastatin on pancreatic endocrine and exocrine secretion. Pancreas 4:277–281.
Janciauskiene, S., Eriksson, S., Carlemalm, E., and Ahren, B., 1997, Beta cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem. Biophys. Res. Commun. 236:580–585.
Kitayama, N., Tateishi, K., Funakoshi, A., Miyasaka, K., Shimazoe, T., Kono, A., Iwamoto, N., and Matsuoka, Y., 1994, Pancreastatin molecular forms in normal human plasma. Life Sciences 54:1571–1578.
Konecki, D.S., Benedum, U.M., Gerdes, H.H., and Huttner, W.B., 1987, The primary structure ofhuman chromogranin A and pancreastatin. J. Biol. Chem. 262:17026–17030.
Leduc, R., Hendy, G.N., Seidah, N.G., Chrétien, M., and Lazure, C., 1990, Fragmentation of bovine chromogranin A by plasma kallikrein. Life Sci. 46:1427–1433.
Lewis, J.J., Zdon, M.J., Adrian, T.E., and Modlin, I.M., 1988, Pancreastatin: a novel peptide inhibitor ofparietal cell secretion. Surgery 104: 1031–1036.
Lewis, J.J., Goldenring, J.R., Asher, V.A., and Modlin, J.M., 1989, Pancreastatin: a novel peptide inhibitor of parietal cell signal transduction. Biochem. Biophys. Res. Commun. 163: 667–673.
Lorinet, A.M., Tatemoto, K., Laburthe, M., and Amiranoff, B., 1989, Pancreastatin inhibits insulin release fiom RIN m5F cells: reversion by pertussis toxin. Eur. J. Pharmacol. 160: 405–407.
Ma, H.T., Kato, M., and Tatemoto, K., 1996, Effects of pancreastatin and somatostatin on secretagogues-induced rise in intracellular free calcium in single rat pancreatic islet cells. Regul. Pept. 61: 143–148.
Miyasaka, K., Funakoshi, A., Nakamura, R., Kitani, K., Shimizu, F., and Tatemoto, K., 1989, Effects of porcine pancreastatin on postprandial pancreatic exocrine secretion and endocrine functions in the conscious rat. Digestion 43: 204–211.
Miyasaka, K., Funakoshi, A., Kitani, K., Tamamura, H., Funakoshi, S., and Fujii, N., 1990, Inhibitory effect of pancreastatin on pancreatic exocrine secretion—pancreastatin inhibits central vagal nerve stimulation. Gastroenterology 99: 1751–1756.
Ohneda, A., Koizumi, F., and Ohneda, M., 1989, Effect of porcine pancreastatin on endocrine function ofcanine pancreas. Tohoku J. Exper. Med. 159: 291–298.
Ostenson, C.G., Efendic, S., and Holst, J.J., 1989a, Pancreastatin-like immunoreactivity and insulin are released in parallel from the perfused porcine pancreas. Endocrinology 124: 2986–2990.
Ostenson, C.G., Sandler, and Efendic, S., 1989b, Effects of porcine pancreastatin on secretion and biosynthesis of insulin and glucose oxidation of isolated rat pancreatic islets. Pancreas 4: 441–446.
Peiró, E., Dégano, P., Miralles, P., Silvestre, R.A., and Marco, J., 1991, Homologous pancreastatin inhibits insulin secretion without affecting glucagon and somatostatin release in the perfused rat pancreas. Regul. Pept. 34: 159–167.
Ravazzola, M., Efendic, S., Östenson, C.G., Tatemoto, K., Hutton, J.C., and Orci, L, 1988, Localization of pancreastatin immunoreactivity in porcine endocrine cells. Endocrinology 123: 227–229.
Sánchez, V., Calvo, J.R., and Gobema, R., 1990, Glycogenolytic effect ofpancreastatin in the rat. Biosci. Rep. 10: 87–91.
Sánchez, V., Lucas, M., Calvo, J.R., and Gobema, R., 1992, Glycogenolytic effect of pancreastatin in isolated rat hepatocytes is mediated by a cyclic-AMP-independent Ca2+-dependent mechanism. Biochem. J. 284: 659–662.
Sánchez-Margalet, V., and Gobema, R., 1993a, Pancreastatin (33–49) enhances the priming effect of glucose in the rat pancreas. Experientia 49: 551–552.
Sánchez-Margalet, V., and Gobema, R., 1993b, Pancreastatin decreases plasma epinephrine levels in surgical stress in the rat. Peptides 14: 797–799.
Sánchez-Margalet, V., and Goberna, R., 1994a, Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes. Regul. Pept. 51: 215–220.
Sánchez-Margalet, V., and Gobema, R., 1994b, Pancreastatin activates pertussis toxin-sensitive guanylate cyclase and pertussis toxin-insensitive phospholipase C in rat liver membranes. J. Cell. Biochem. 55: 173–181.
Sánchez-Margalet, V., and Santos-Alvarez, J., 1997, Solubilization and Molecular characterization of pancreastatin receptors fiom rat liver membranes. Endocrinology 138: 1712–1718.
Sánchez-Margalet, V., and González-Yanes, C., 1998, Pancreastatin inhibits insulin action in rat adipocytes. Am. J. Physiol. 275: E1055–1060.
Sánchez-Margalet, V., Calvo, J.R., Lucas, M., and Goberna, R., 1992a, Pancreastatin and its 33–49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo. Gen. Phannacol. 23: 637–638.
Sánchez-Margalet, V., Calvo, J.R., and Goberna, R., 1992b, Glycogenolytic and hyperglycemic effect of 33–49 C-terminal fragment of pancreastatin in the rat in vivo. Horm. Metab. Res. 24: 455–457.
Sánchez-Margalet, V., Lucas, M., and Gobema, R., 1993, Pancrestatin increases free cytosolic Ca2+ in rat hepatocytes involving both pertussis toxin-sensitive and-insensitive mechanisms. Biochem. J. 294: 439–42.
Sánchez-Margalet, V., Lucas, M., and Goberna, R., 1994a, Pancreastatin activates protein kinase C by stimulating the formation of 1,2-diacylglycerol in rat hepatocytes. Biochem. J. 303: 51–54.
Sánchez-Margalet, V., Valle, M., and Goberna, R., 1994b, Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking. Mol. Pharmacol. 46: 24–29.
Sánchez-Margalet, V., Valle, M., Lobón, J.A., Maldonado, A., Escobar, F., Oliván, J., Perez-Cano, R., and Goberna, R., 1995a, Increased pancreastatin-like immunoreactivity levels in non-obese patients with essential hypertension. J. Hypertension 13: 251–258.
Sánchez-Margalet, V., Valle, M., Lobón, J.A., Escobar-Jiménez, F., Perez-Cano, R., and Goberna, R., 1995b, Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension. Neuropeptides 29: 97–101.
Sánchez-Margalet, V., Lucas, M., and Goberna, R., 1996a, Pancreastatin: further evidence for its consideration as a regulatory peptide. J. Mol. Endocrinol. 16: 1–8.
Sánchez-Margalet, V., Lucas, M., and Goberna, R., 1996b, Pancreastatin action in the liver: dual coupling to different G proteins. Cell. Signal. 8: 9–12.
Sánchez-Margalet, V., Lobón, J.A., González, A., Escobar-Jiménez, F., and Goberna, R., 1998, Increased plasma pancreastatin-like levels in gestational diabetes subjects. Correlation with plasma catecholamine levels. Diabetes Care 21: 1951–1954.
Sánchez-Margalet, V., González-Yanes, C., Santos-Alvarez, J., and Najib, S., 2000, Characterization of pancreastatin receptor and signaling in HTC rat hepatoma cells. Eur. J. Pharmacol. (in press)
Sánchez-Margalet, V., 1999, Modulation of insulin receptor signalling by pancreastatin in HTC hepatoma cells. Diabetologia 42: 317–325.
Santos-Alvarez, J., and Sánchez-Margalet, V., 1998, Pancreastatin activates b3 isofonn of phospholipase C via Ga11 protein stimulation in rat liver membranes. Mol. Cell. Endocrinol. 143: 101–106.
Santos-Alvarez, J., and Sánchez-Margalet, V., 1999, G protein Gcq/11 and GaiI,2 are activated by pancreastatin receptors in rat liver. Studies with GTP-y-35S and Aziido-GlTy-32p. J. Cell. Biochem. 73:469–477.
Santos-Alvarez, J., Sánchez-Margalet, V., 2000, Puification of pancreastatin receptor associated with Gq/l1 from rat liver membranes. Arch. Biochem. Biophys. (in press).
Santos-Alvarez, J., González-Yanes, C, and Sánchez-Margalet, V., 1998, Pancreastatin receptor is coupled to a guanosine triphosphate-binding protein of the Gq/1 1a family in rat liver membranes. Hepatology 27: 608–614.
Schmidt, W.E., Binder, G., Gallwitz, B., Siegel, E.G., Creutzfeldt, W., 1987, C-terminal fragments of pancreastatin inhibit GIP-induced insulin secretion in isolated rat pancreatic islets. Diabetologia 30: 579A.
Schmidt, W.E., Siegel, E.G., and Creutzfeldt, W., 1988, Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A. Proc. Natl. Acad. Sci. USA 85: 8231–8235.
Sekiya, K., Haji, M., Fukahori, M., Takayanagi, R., Ohashi, M., Kurose, S., Oyamama, M., Tateishi, K., Funakoshi, A., Nawata, H., 1994, Pancreastatin-like immunoreactivity of cerebrospinal fluid in patients with Alzheimer type dementia: evidence of aberrant processing ofpancreastatin in Alzheimer type dementia Neurosci. Lett. 177: 123–126.
Silvestre, R.A., Peiró, E., Miralles, P., Villanueva, M.L., and Marco, J., 1988, Effects of pancreastatin on insulin, glucagon and somatostatin secretion by the perfused rat pancreas. Life Sci. 42: 1361–1367.
Sjoholm, A., Funakoshi, A., Efendic, E., Östenson, C.G., and Hellerstrom, C., 1991, Long term inhibitory effect of pancreastatin and diacepan binding inhibitor on pancreatic beta-cell deoxyribonucleic acid replication, polyamine content, and insulin secretion. Endocrinology 128: 3277–3282.
Smith, J.P., and Kramer, S.T., 1989, Pancreastatin inhibits growth of pancreatic cancer. Gastroenterology 96: A479.
Smith, J.P., Kramer, S.T., and Bagheri, S., Effects of pancreastatin (24–49) on growth of normal pancreas and pancreatic cancer. Pancreas 6: 551–557.
Syversen, U., Mignon, M., Bofils, S., Kristensen, A., and Waldum, H.L., 1993, Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncologica 32: 161–165.
Tamamura, H., Ohta, M., Yoshizawa, K., and Ono, Y., 1990, Isolation and characterization of a tumor-derived human protein related to chromogranin A and its in vitro conversion to human pancrastatin-48. Eur. J. Biochem. 191: 33–39.
Tatemoto, K., Efendic, S, Mutt, V., Makk, G, Feistner,. G.J., and Barchas, J.D., 1986, Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324: 476–478.
Von Schonfeld, J., Muller, M.K., Runzi, M., Geling, M., Neisius, I., Kleimann, J., and Goebell, H., 1993, Pancreastatin—a mediator in the islet-acinar axis? Metabolism 42: 552–555.
Watkinson, A., Jonsson, A.C., Davidson, M., Young, J., Lee, C.M., Moore, S., and Dockray, G.J., 1991, Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla. Biochem. J. 276: 471–479.
Watkinson, G., Rogers, M., and Dockray, A., 1993, Post-translational processing of chromogranin A differential distribution of phosphorylated variants of pancreastatin and fragments 248–3 13 and 297–3 13 in bovine pancreas and ileum. Biochem. J. 295: 649–654.
Zhang, J.-X., Fasciotto, B.H., Darling, D.S., and Cohn, D.V., 1994, Pancreastatin, a chromogranin A-derived peptide, inhibits transcription of the parathyroid hormone and chromogranin A genes and decreases the stability of the respective messenger ribonucleic acids in parathyroid cells in culture. 134: 1310–1316.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Sánchez-Margalet, V., González-Yanes, C., Santos-Alvarez, J., Najib, S. (2002). Pancreastatin. In: Helle, K.B., Aunis, D. (eds) Chromogranins. Advances in Experimental Medicine and Biology, vol 482. Springer, Boston, MA. https://doi.org/10.1007/0-306-46837-9_20
Download citation
DOI: https://doi.org/10.1007/0-306-46837-9_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46446-1
Online ISBN: 978-0-306-46837-7
eBook Packages: Springer Book Archive